A gastrostomy is a feeding tube that is inserted directly into the stomach either surgically under direct vision (open or laproscopic), endoscopically (with a camera), or radiologically (x-ray guidance). A gastrostomy tube allows the delivery of supplemental nutrition and medications directly into the stomach. It also provides a mechanism to drain gastric contents if required. In order for gastrostomy feeding to be successful the child or young person must have a functioning gastrointestinal tract.
The aim of this guideline is to support staff in ensuring the prompt assessment, recognition and treatment of jaundice, while minimizing the risks of unintended harm such as parental anxiety, decreased breastfeeding, and unnecessary costs or treatment.
This page explains about transgastric jejunal feeding devices (also known as gastrojejunostomy or GJ devices), how they are inserted at Great Ormond Street Hospital (GOSH) and how you will need to look after it once you return home.
This guideline describes the procedure which must be followed whenever a diagnosis of Mycobacterium Tuberculosis (M.TB) infection is suspected or confirmed, to optimally protect staff, patients and other visitors from risk of infection and assist in the care of the child with M.TB (not including Occupational Health policy).
A gastrostomy is a surgical opening through the abdomen into the stomach. A feeding device is inserted through this opening. This allows your child to be fed directly into their stomach, bypassing the mouth and throat.
This guideline is intended to guide and facilitate the care of patients under the care of the clinical teams at Great Ormond Street Hospital for Children NHS Trust (GOSH). The guidance contained herein is not intended to replace individual assessment and personalised treatment of the patient.
The ketogenic diet (KD) is a therapeutic diet, which has been shown to improve seizure control in patients with drug resistant epilepsy, and is used in some patients with metabolic conditions for example, glucose transporter type 1 deficiency syndrome (GLUT1) and pyruvate dehydrogenase deficiency (PDH).
We have an ongoing programme of research, and you or your child may be invited to take part in a research project whilst under the care of the team. This is always entirely voluntary, and whether you choose to participate or not, your clinical care will not be affected. Any information gathered may be used anonymously for research purposes to improve our understanding and lead to better treatments for other children and families in the future.
Clinical outcomes are broadly agreed, measurable changes in health or quality of life that result from our care. Constant review of our clinical outcomes establishes standards against which to continuously improve all aspects of our practice.
The key to dealing with medicines effectively is to understand them. This information aims to explain a little more about how medicines are organised in the UK, understanding your prescription and who to ask for more information.